Surgery News and Research

RSS

Persistent high cortisol levels increase hypertension risk in patients with adrenal tumors

A major new study, published today in The Lancet Diabetes & Endocrinology has shown that cortisol levels in patients with adrenal tumours are far less stable than previously assumed.

7 Jul 2026

USC researcher wins NIH grant to study how the cochlea processes complex sounds

USC researcher Karolina Charaziak, PhD, has been awarded a $3.3 million National Institutes of Health (NIH) Research Project (R01) grant to study how the cochlea, the part of the inner ear responsible for hearing, processes complex sounds encountered in everyday life.

7 Jul 2026

Smart medical wristband tracks hidden arrhythmias to prevent strokes

According to the World Health Organization, cardiovascular diseases claim almost 20 million lives every year and remain the leading cause of death worldwide.

7 Jul 2026

Estonian study highlights value of early genetic tests to identify hereditary cancer risks

In 2013, Angelina Jolie inspired a wave of testing for pathogenic variants of the gene BRCA1 by announcing that she carried a variant which left her at such high risk of breast cancer, she chose a preventive mastectomy.

7 Jul 2026

U.S. obesity rates rose sharply between 1999 and 2023

Obesity rates among U.S. adults and children rose sharply in recent years and by 2023, 40% of adults and 20% of youth met the criteria for obesity, according to new, independent research published today in the American Heart Association's flagship journal Circulation.

7 Jul 2026

Blood hormone signature could transform endometriosis diagnosis

People with endometriosis have a distinct pattern of hormones which could be identified by a blood test, with the potential to revolutionise diagnosis of the condition, research suggests.

6 Jul 2026

Study identifies promising drug target to prevent neurodegenerative conditions

Parkinson's disease (PD) is the second most common form of neurodegenerative disease and afflicts more than ten million people worldwide. While current therapies address disease symptoms, they do not prevent the underlying neurodegeneration that drives the disease.

6 Jul 2026

Case study shows how accurate diagnosis can guide personalized treatment for renal oncocytoma

A new case report was published in Volume 17 of Oncotarget on July 2, 2026, titled "Renal oncocytoma: Α case report and literature review."

6 Jul 2026

Targeted therapy shows promise against KRAS-driven metastatic pancreatic cancer

An investigational targeted therapy designed to block one of the most common genetic drivers of pancreatic cancer has shown promising early results when combined with standard first-line chemotherapy, according to research presented today at the ESMO Gastrointestinal Cancers Congress 2026.

3 Jul 2026

Blood test may predict which colorectal cancer patients benefit from chemotherapy

A blood test may help identify which patients with colorectal cancer that has spread to the liver are most likely to benefit from chemotherapy after surgery, according to research presented today at the ESMO Gastrointestinal Cancers Congress 2026.

3 Jul 2026

New synthetic grafting material kills bone cancer and regenerates bone

Primary bone tumors, such as osteosarcoma, have seen stagnant survival rates over the past four decades. Surgical removal of the tumor is critical, but local recurrence may occur when tumours are close to vital structures, often resulting in amputation

3 Jul 2026

New breast cancer classification system predicts immunotherapy response success

The advent of immune checkpoint inhibitors (ICIs) has marked a paradigm shift in cancer treatment, yet a significant portion of breast cancer patients fail to respond to these therapies.

3 Jul 2026

Study reveals how specific aging cells help repair injured tendons

Tendon injuries, though very common, frequently heal with scar tissue, which is less flexible and more prone to future injury.

3 Jul 2026

$Large trial validates dual mobility implants for hip fracture treatment$

Large trial validates dual mobility implants for hip fracture treatment

A major international clinical trial led by Queen Mary University of London and Uppsala University in Sweden has found that an emerging type of hip replacement implant dramatically reduces complications in people with a broken hip.

2 Jul 2026

Dual-mobility hip implant lowers dislocation risk after replacement surgery

A new type of hip replacement implant reduces the risk of joint dislocation after surgery by 70 per cent. This is the finding of a new study involving 1,600 patients across 44 hospitals in Sweden and the UK, as published in The Lancet.

2 Jul 2026

New safety strategies reduced serious surgical events in children

Ann & Robert H. Lurie Children's Hospital of Chicago achieved more than a 13-fold improvement in surgical safety after implementing a series of interventions based on high reliability principles across its operating rooms.

1 Jul 2026

Opioid prescribing after pediatric surgery varies widely across hospitals

Whether children receive an opioid prescription after surgery varies substantially by procedure type and hospital, according to a new national analysis published in the Journal of the American College of Surgeons (JACS).

1 Jul 2026

Biological heart valves support safer pregnancies despite reoperation risks

In severe disease of the aortic valve, choosing a new heart valve is especially difficult for young women who want to become pregnant.

1 Jul 2026

CAR-T cell therapy shows potential to eliminate aggressive glioblastoma

A study led by a researcher based at King's College London and McMaster University in Canada reveals how CAR-T cell therapy, a treatment that engineers a patient's own immune cells to recognize and attack cancer, could be used to treat glioblastoma.

1 Jul 2026

Study links semaglutide and tirzepatide to fewer anxiety and depression diagnoses in obesity care

A US electronic health record study found that adults with obesity who started semaglutide or tirzepatide had lower recorded hazards of anxiety and depression than matched patients using naltrexone-bupropion. However, among adults without type 2 diabetes, tirzepatide was linked to higher recorded hazards of anxiety and insomnia than semaglutide, underscoring the need for cautious monitoring.

1 Jul 2026